Ryan Breslow, who stepped down as Bolt Financial CEO in January, launches Love, a DAO to fund clinical trials in alternate medicine, with $7.5M in funding
The controversial founder and executive chairman of payment company Bolt slides into the CEO seat of an early-stage wellness startup.
Context & Ripple Effects
Ryan Breslow stepped down as Bolt Financial's CEO in January while keeping a 25% stake worth roughly $2.75B, according to profiles at the time (his post-departure stake profile). Love is his first move into that vacuum: a DAO raising $7.5M to fund clinical trials in alternative medicine, with Breslow sliding from executive chairman of a payments company into the CEO seat of an early-stage wellness startup.
The launch also reads against the backdrop of his Bolt troubles — the $355M Series E that set off 18 months of lawsuits and a showdown with early backer Activant — making Love both a reputation project and a test of whether Breslow's name attracts capital outside payments.
First-order effects
- Breslow now runs two companies at once: he remains executive chairman of Bolt while taking the CEO role at Love, splitting his attention between a payments firm in turmoil and an unproven wellness venture.
- The $7.5M goes directly toward funding clinical trials for alternative-medicine products, giving Love a research pipeline most supplement startups lack at formation.
Second-order effects
- Clinical-trial results become Love's marketing asset: if the DAO-funded studies validate its products, they differentiate a wellness brand in a category where rivals typically compete on claims rather than evidence.
- The DAO structure lets retail contributors underwrite research a traditional VC would not touch, shifting who funds early-stage health science and what gets studied.
Third-order effects
- If the model holds, it points toward consumer-health companies built as tokenized communities that finance their own evidence generation — and toward founders like Breslow treating venture-building as a portfolio spanning fintech, wellness, and crypto governance simultaneously.
The trend: Fintech founders are recycling their equity windfalls into consumer-wellness ventures that use DAO fundraising and clinical-trial claims as their core differentiator.